What are prairie dogs notorious for? Monkeypox and HIV infection

1. Bunge E.M., Hoet B., Chen L., Lienert F., Weidenthaler H., Baer L.R. et al. The changing epidemiology of human monkeypox – A potential threat? A systematic review. PLoS Negl. Trop. Dis. 2022; 16(2): e0010141. DOI: 10.1371/journal.pntd.0010141

2. Reynolds M.G., Davidson W.B., Curns A.T., Conover C.S., Huhn G., Davis J.P. et al. Spectrum of infection and risk factors for human monkeypox, United States, 2003. Emerg. Infect. Dis. 2007; 13(9): 332–339. DOI: 10.3201/eid1309.070175

3. Yong S.E.F., Ng O.T., Ho Z.J.M., Mak T.M., Marimuthu K., Vasoo S. et al. Imported monkeypox, Singapore. Emerg. Infect.Dis. 2020; 26(8): 1826–1830. DOI: 10.3201/eid2608.191387

4. Vaughan A., Aarons E., Astbury J., Brooks T., Chand M., Flegg P. et al. Human-to-human transmission of monkeypox virus, United Kingdom, October 2018. Emerg. Infect. Dis. 2020; 26(4): 782–785. DOI: 10.3201/eid2604.191164

5. Seang S., Burrel S., Todesco E., Leducq V., Monsel G., Le Pluart D. et al.. Evidence of human-to-dog transmission of monkeypox virus. Lancet 2022; 400(10353): 658–659. DOI: 10.1016/S0140-6736(22)01487-8

6. Reda A., Sah R., Rodriguez-Morales A.J., Shah J. Viral replication and infectivity of monkeypox through semen. Lancet Infect. Dis. 2022; 22(11): 1531–1532. DOI: 10.1016/S1473-3099(22)00611-9

7. Lapa D., Carletti F., Mazzotta V., Matusali G., Pinnetti C., Meschi S. et al. Monkeypox virus isolation from a semen sample collected in the early phase of infection in a patient with prolonged seminal viral shedding. Lancet Infect. Dis. 2022; 22: 1267–1269. DOI: 10.1016/S1473-3099(22)00513-8

8. Adler H., Gould S., Hine P., Snell L.B., Wong W., Houlihan C.F. et al. Clinical features and treatment of monkeypox in humans: a retrospective observational study in the UK. Lancet Infect. Dis. 2022; 22: 1153–1162. DOI: 10.1016/S1473-3099(22)00228-6

9. Nolen L.D., Osadebe L., Katomba J., Likofata J., Mukadi D., Monroe B. et al. Extended human-to-human transmission during a monkeypox outbreak in the Democratic Republic of the Congo. Emerg. Infect. Dis. 2016; 22(6): 1014–1021. DOI: 10.3201/eid2206.150579

10. Titanji B.K., Hazra A., Zucker J. Mpox Clinical Presentation, Diagnostic Approaches, and Treatment Strategies: A Review. JAMA 2024; 332(19): 1652–1662. DOI: 10.1001/jama.2024.21091

11. Ilic I., Zivanovic Macuzic I., Ilic M. Global Outbreak of Human Monkeypox in 2022: Update of Epidemiology. Trop. Med. Infect. Dis. 2022; 7(10): 264. DOI: 10.3390/tropicalmed7100264

12. Secco M., Silva T., Coutinho C., Torres T.S., Peixoto E., Ismério et al. Ambulatory and hospitalized patients with suspected and confirmed mpox: an observational cohort study from Brazil. Lancet Reg. Health Am. 2023; 17: 100406. DOI: 10.1016/j.lana.2022.100406

13. Maan I., Kohli M., Gilson R. Mpox in people living with HIV. Curr. Opin. Infect. Dis. 2024; 37(1): 1–7. DOI: 10.1097/QCO.0000000000000994

14. Hoffmann C., Jessen H., Wyen .C., Grunwald S., Noe S., Teichmann J. et al Clinical characteristics of monkeypox virus infections among men with and without HIV: A large outbreak cohort in Germany. HIV Med. 2023; 24(4): 389–397. DOI: 10.1111/hiv.13378

15. Леонтьева Н.И., Антипят Н.А., Гопаца Г.В., Соловьева А.И., Виноградов Н.А. Оспа обезьян: клинико-эпидемиологические особенности распространения в России по материалам инфекционного стационара в 2024 г. Эпидемиология и инфекционные болезни 2025; 30(2): 97–100. [Leonteva N.I., Antipyat N.A., Gopatsa G.V., Soloveva A.I., Vinogradov N.A. Smallpox of monkeys: clinical and epidemiological features of the spread in Russia based on the materials of the infectious diseases hospital in 2024. Epidemiology and Infectious Diseases 2025; 30(2): 97–100. (In Russ.)]. DOI: 10.51620/3034-1981-2025-30-2-97-100

16. Mitja O., Alemany A., Marks M., Mora J.I.L., Rodriguez-Aldama J.C., Silva M.S. et al. Mpox in people with advanced HIV infection: a global case series. Lancet 2023; 401(10380): 939–949. DOI: 10.1016/S0140-6736(23)00273-8

17. Wang F., Fang Y., Zhou Z., Liu С., Ji J., Jia L. et al. Clinical and radiological features of severe mpox: a case series of 16 patients in Beijing, China. BMC Infect. Dis. 2026; 26: 348. DOI: 10.1186/s12879-026-12626-x

18. Curran K.G., Eberly K., Russell O.O., Snyder R.E., Phillips E.K., Tang E.C. et al. HIV and sexually transmitted infections among persons with Monkeypox — eight U.S. jurisdictions, may 17–July 22, 2022. MMWR Morb. Mortal. Wkly. Rep. 2022; 71: 1141–1147 DOI: 10.15585/mmwr.mm7136a1

19. Jia L., Yan B., Fang Y., Yang X., Jia H., Zhang M. et al. Cases of Monkeypox show highly-overlapping co-infection with HIV and syphilis. Front. Public Health 2024; 11: 1276821. DOI: 10.3389/fpubh.2023.1276821

20. Aldred B., Scott J.Y., Aldredge A., Gromer D.J., Anderson A.M., Cartwright E.J. et al. Associations between HIV and severe Mpox in an Atlanta cohort. J. Infect. Dis. 2024; 229(Suppl. 2): S234–S242. DOI: 10.1093/infdis/jiad505

21. Lima M.T., Kroon E.G., Campos M.A. Mpox and the impact on people with HIV. Curr. Opin. HIV AIDS 2025; 20(3): 310–317. DOI: 10.1097/COH.0000000000000922

22. Saldana C.S., Kelley C.F., Aldred B.M., Cantos V.D. Mpox and HIV: a Narrative Review. Curr. HIV/AIDS Rep. 2023; 20(4): 261–269. DOI: 10.1007/s11904-023-00661-1

23. Rizk Y., Lippi G., Henry B.M., Notarte K.I., Rizk J.G. Update on Mpox Management: Epidemiology, Vaccines and Therapeutics, and Regulatory Changes. Drugs 2025; 85(1): 1–9. DOI: 10.1007/s40265-024-02117-1.

24. Bryant A.E., Stanford T. Shulman Mpox: emergence following smallpox eradication, ongoing outbreaks and strategies for prevention. Curr. Opin. Infect. Dis. 2025; 38(3): 222–227. DOI: 10.1097/QCO.0000000000001100